CA2125293A1 - Traitement du cancer colorectal - Google Patents
Traitement du cancer colorectalInfo
- Publication number
- CA2125293A1 CA2125293A1 CA002125293A CA2125293A CA2125293A1 CA 2125293 A1 CA2125293 A1 CA 2125293A1 CA 002125293 A CA002125293 A CA 002125293A CA 2125293 A CA2125293 A CA 2125293A CA 2125293 A1 CA2125293 A1 CA 2125293A1
- Authority
- CA
- Canada
- Prior art keywords
- course
- day
- therapy
- hydroxy
- repeated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80457091A | 1991-12-10 | 1991-12-10 | |
US07/804,570 | 1991-12-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2125293A1 true CA2125293A1 (fr) | 1993-06-24 |
Family
ID=25189304
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002125293A Abandoned CA2125293A1 (fr) | 1991-12-10 | 1992-07-24 | Traitement du cancer colorectal |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0661977A1 (fr) |
JP (1) | JPH07501818A (fr) |
AU (1) | AU2394392A (fr) |
CA (1) | CA2125293A1 (fr) |
MX (1) | MX9205766A (fr) |
PT (1) | PT100948A (fr) |
WO (1) | WO1993011770A1 (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5552154A (en) | 1989-11-06 | 1996-09-03 | The Stehlin Foundation For Cancer Research | Method for treating cancer with water-insoluble s-camptothecin of the closed lactone ring form and derivatives thereof |
DK0678025T3 (da) * | 1993-01-15 | 1998-10-07 | Stehlin Foundation For Cancer | Transdermal behandling af cancer med vand-ouopløslig S-camptothecin af den lukkede lactonringform |
US6291425B1 (en) * | 1999-09-01 | 2001-09-18 | Guilford Pharmaceuticals Inc. | Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
ES2371171B1 (es) * | 2010-06-08 | 2012-11-16 | Consejo Superior De Investigaciones Científicas (Csic) | Derivados de camptotecina como agentes antitumorales. |
CN102477042A (zh) * | 2010-11-26 | 2012-05-30 | 复旦大学 | 10-羟基喜树碱衍生物及其制备方法和用途 |
CN102659800B (zh) * | 2012-05-11 | 2014-09-03 | 中国药科大学 | 一类低氧激活抗肿瘤化合物及其用途 |
CN103113381B (zh) * | 2013-02-26 | 2014-12-10 | 大连理工大学 | 系列水溶性羟基喜树碱环烷胺醇衍生物及其制法与用途 |
CA3168882A1 (fr) | 2020-02-25 | 2021-09-02 | Mediboston, Inc. | Derives de camptothecine et leurs utilisations |
CN116270641A (zh) * | 2023-03-09 | 2023-06-23 | 兰州大学 | 喜树碱类衍生物在制备治疗膀胱癌药物中的应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5004758A (en) * | 1987-12-01 | 1991-04-02 | Smithkline Beecham Corporation | Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells |
JPH0641161B2 (ja) * | 1988-02-17 | 1994-06-01 | 積水化成品工業株式会社 | スチレン系樹脂発泡シートの製造方法及び加熱成形用スチレン系樹脂発泡シート |
JPH0768403B2 (ja) * | 1988-12-15 | 1995-07-26 | 東洋エンジニアリング株式会社 | 発泡体の製造方法 |
JP2756366B2 (ja) * | 1990-11-27 | 1998-05-25 | 松下電工株式会社 | 疎水性エアロゲルの製造方法 |
-
1992
- 1992-07-24 EP EP92916470A patent/EP0661977A1/fr not_active Withdrawn
- 1992-07-24 AU AU23943/92A patent/AU2394392A/en not_active Abandoned
- 1992-07-24 JP JP5510863A patent/JPH07501818A/ja active Pending
- 1992-07-24 CA CA002125293A patent/CA2125293A1/fr not_active Abandoned
- 1992-07-24 WO PCT/US1992/006131 patent/WO1993011770A1/fr not_active Application Discontinuation
- 1992-10-08 MX MX9205766A patent/MX9205766A/es unknown
- 1992-10-09 PT PT100948A patent/PT100948A/pt not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0661977A4 (fr) | 1994-10-20 |
WO1993011770A1 (fr) | 1993-06-24 |
JPH07501818A (ja) | 1995-02-23 |
MX9205766A (es) | 1993-06-01 |
PT100948A (pt) | 1994-01-31 |
EP0661977A1 (fr) | 1995-07-12 |
AU2394392A (en) | 1993-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0612248B1 (fr) | composition contenant le cisplatin et le topotécane comme agent antitumoral | |
WO2000056297A2 (fr) | Compositions favorisant la croissance | |
WO2004043389B1 (fr) | Procedes de traitement du cancer et procedes connexes | |
CA2125293A1 (fr) | Traitement du cancer colorectal | |
Burke et al. | Imidazole carboxamide therapy in advanced malignant melanoma | |
AU664172B2 (en) | Treatment of esophageal cancer | |
CA2103707C (fr) | Traitement des carcinomes pulmonaires autres que le cancer pulmonaire a petites cellules | |
EP0338679A2 (fr) | Utilisation du facteur necrosant des tumeurs dans le traitement du cancer de la vessie | |
EP1707568B1 (fr) | Composition pharmaceutique utilisée dans le traitement du cancer de l'ovaire | |
UA69423C2 (uk) | Засіб для лікування пухлини печінки шляхом введення метоксиморфолінодоксорубіцину (mmdx) через печінкову артерію (варіанти) | |
CA2501610C (fr) | Derives epothilone pour le traitement du myelome multiple | |
CA2501717C (fr) | Utilisation de derives d'epothilone pour le traitement de l'hyperparathyroidie | |
US3764679A (en) | Iodinin as an anti-hypertensive agent | |
JP2002104972A (ja) | トポイソメラーゼ阻害剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |